CureVac (CDMO Services)

Tubingen, DE
Find alternatives to CureVac (CDMO Services) for mRNA →
Hybrid — also manufactures internal programs
4 confirmed programs · 1 sponsors · Last scored 2026-10-29
75.3
Signal Score
○ FDA Inspections ✓ Clinical Trials (4) ○ SEC Filings ○ Press ✓ EMA GMP (7) ○ MHRA GMP

Quick Facts: CureVac (CDMO Services)

Signal Score
75.3/100 (as of 2026-10-29)
Quality Compliance
100.0/100 — Clean EMA record: 7 active GMP certificates (no deductions)
Headquarters
Tubingen, DE
Modalities
mRNA
Active Programs
4 confirmed from ClinicalTrials.gov across 1 sponsors
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About CureVac (CDMO Services)

mRNA pioneer with CDMO capabilities.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
Clean EMA record: 7 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 7 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates7 on record
Clean EMA record: 7 active GMP certificates (no deductions)
Operations 52.5
4 active programs across 1 sponsors
Modalities: mRNA
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
4 active programs across 1 sponsors · Modalities: mRNA · 1 programs in advanced phases (Phase 2/3)
Programs 4
Sponsors1
ModalitiesmRNA
4 active programs across 1 sponsors
Modalities: mRNA
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT07073183 Safety and Tolerability of CVHNLC Plus Pembrolizumab in... PHASE1 Withdrawn
NCT03291002 Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC PHASE1 Unknown
NCT01915524 Trial of RNActive®-Derived Cancer Vaccine and Local Radiation... PHASE1 Terminated
NCT00923312 Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV... PHASE1/PHASE2 Completed
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Financial Stability 83.0
Publicly traded — financial transparency
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
Capacity 53.0
1 manufacturing site: Tubingen, Germany
Modalities: mRNA
Capacity assessment: 53.0/100
Sites: Tubingen, Germany
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Tubingen, Germany
Modalities: mRNA
Capacity assessment: 53.0/100

CureVac (CDMO Services) EMA GMP Compliance 7 certificates

2025-11
2025-11
2025-11
2024-12
2023-09
2023-09
2023-05
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
DE_BW_01_GMP_2026_0102 CureVac Manufacturing GmbH Germany 2025-11-13 COMPLIANT
DE_BW_01_GMP_2026_0103 CureVac Manufacturing GmbH Germany 2025-11-13 COMPLIANT
DE_BW_01_GMP_2026_0101 CureVac Manufacturing GmbH Germany 2025-11-13 COMPLIANT
DE_BW_01_GMP_2025_0094 CureVac Manufacturing GmbH Germany 2024-12-17 COMPLIANT
DE_BW_01_GMP_2024_0013 CureVac Manufacturing GmbH Germany 2023-09-28 COMPLIANT
DE_BW_01_GMP_2024_0012 CureVac Manufacturing GmbH Germany 2023-09-28 COMPLIANT
DE_BW_01_GMP_2023_0203 CureVac RNA Printer GmbH Germany 2023-05-23 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business, and we can't yet tell which of those roles belong to it. Why: the board covers the whole group and doesn't say which business unit a role belongs to. We'd rather show no number than one that isn't really this company's.
Source: career.curevac.com · Checked Nov 20, 2026

Frequently Asked Questions About CureVac (CDMO Services)

Does CureVac (CDMO Services) hold EMA or MHRA GMP certificates?
CDMO Signal tracks 7 EMA GMP certificates for CureVac (CDMO Services).
How many clinical programs is CureVac (CDMO Services) linked to?
CureVac (CDMO Services) is associated with 4 clinical trials in CDMO Signal's ClinicalTrials.gov-sourced data.
What is CureVac (CDMO Services)'s CDMO Signal Score?
CureVac (CDMO Services) has a Signal Score of 75/100, based on quality, operations, financial stability, and capacity data.
Evaluating CureVac (CDMO Services) for a manufacturing program?
Use the free AI matchmaker to compare CureVac (CDMO Services) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
mRNA CDMOs →

Similar CDMOs

Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Signal Score: 82.9
Recombinant Protein, Plasmid DNA, mRNA, Microbial Fermentation
BioNTech (Mfg Services)
Mainz, DE · Marburg, DE
Signal Score: 82.1
mRNA
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
Ethris
Planegg, DE
Signal Score: 56.5
mRNA

Compare CureVac (CDMO Services) with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on CureVac (CDMO Services)
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.